Astria Therapeutics, Inc.
ATXS
$4.04
$0.061.51%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -4.69% | -2.94% | -4.11% | 50.05% | 30.57% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -14.10% | 150.74% | -32.08% | 0.88% | 76.69% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | 0.00% | -- | -- |
Total Current Assets | -4.89% | -1.68% | -4.44% | 49.25% | 31.06% |
|
|||||
Total Current Assets | -4.89% | -1.68% | -4.44% | 49.25% | 31.06% |
Net Property, Plant & Equipment | -5.12% | -5.69% | 2,621.43% | -42.15% | -29.38% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -40.58% | 0.02% | 7.58% | 21.27% | 78.68% |
Total Assets | -5.33% | -1.73% | -2.86% | 48.75% | 31.37% |
|
|||||
Total Accounts Payable | 238.03% | -45.41% | 171.58% | -43.03% | 32.95% |
Total Accrued Expenses | 2.74% | 2.25% | 27.29% | 3.44% | 25.17% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 0.51% | 10.60% | 641.07% | -48.94% | -32.58% |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 21.67% | -3.93% | 47.83% | -4.14% | 23.11% |
|
|||||
Total Current Liabilities | 21.67% | -3.93% | 47.83% | -4.14% | 23.11% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -6.85% | -6.23% | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 15.59% | -4.43% | 88.87% | -4.14% | 23.11% |
|
|||||
Common Stock & APIC | 0.38% | 2.14% | 0.41% | 19.85% | 14.11% |
Retained Earnings | -3.95% | -3.93% | -4.03% | -3.43% | -5.72% |
Treasury Stock & Other | -50.76% | 835.56% | -221.43% | -- | -- |
Total Common Equity | -9.09% | -2.15% | -7.58% | 84.32% | 65.77% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
|
|||||
Total Common Equity | -9.09% | -2.15% | -7.58% | 84.32% | 65.77% |
Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -6.55% | -1.56% | -5.62% | 51.26% | 31.79% |
|